Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
60 studies found for:    HPC3
Show Display Options
Rank Status Study
1 Completed A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.
Condition: Healthy Volunteers
Interventions: Drug: TMC435 150 mg capsule;   Drug: TMC435 150 mg oral suspension (20 mg/mL);   Drug: TMC435 150 mg oral solution (10 mg/mL);   Drug: TMC435 150 mg capsule concept K;   Drug: TMC435 150 mg capsule concept L
2 Recruiting Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Condition: Preterm Birth
Interventions: Drug: Hydroxyprogesterone Caproate Injection, 250mg/mL;   Drug: Vehicle
3 Terminated TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin
Condition: Hepatitis C Virus
Interventions: Drug: placebo.;   Drug: TMC649128.;   Drug: placebo;   Drug: TMC649128
4 Completed Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate
Condition: Allergic Contact Dermatitis
Intervention: Drug: Goldnatriomthiosulphate, MDBGN, parthenolide
5 Completed Cognitive Behavioral Stress Management for HIV+ Drug Abusers
Conditions: HIV/AIDS;   Drug Abuse;   Alcohol Abuse
Intervention: Behavioral: Cognitive Behavioral Stress Management
6 Active, not recruiting Scleroderma: Cyclophosphamide or Transplantation (SCOT)
Conditions: Scleroderma, Systemic;   Sclerosis;   Autoimmune Disease
Interventions: Procedure: Autologous stem cell transplantation;   Drug: Cyclophosphamide;   Drug: Antithymocyte globulin, equine;   Drug: Methylprednisolone;   Drug: Growth colony stimulating factor (G-CSF);   Radiation: Total body irradiation (TBI)
7 Active, not recruiting 3-year Follow-up Study in Patients Previously Treated With a TMC435 for the Treatment of Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C
Intervention: Drug: No treatment
8 Completed
Has Results
The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)
Conditions: Non-Hodgkin Lymphoma;   Hodgkin Disease
Interventions: Drug: G-CSF plus plerixafor;   Biological: rituximab
9 Completed TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy
Condition: Hepatitis C
Interventions: Drug: TMC435;   Drug: TVR
10 Not yet recruiting Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection
Conditions: Chronic Hepatitis C;   Genotype 4 Chronic Hepatitis C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir
11 Not yet recruiting Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection
Conditions: Chronic Hepatitis C;   Genotype 4 Chronic Hepatitis C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir
12 Recruiting An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant
Condition: Hepatitits C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir;   Drug: Ribavirin
13 Completed Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Behavioral: Teacher Help for ADHD
14 Completed A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TMC647055 in Combination With Ritonavir (Part 1) and the Co-administration of TMC435, TMC647055 and Ritonavir (Part 2) in Healthy Japanese Participants
Condition: Healthy
Interventions: Drug: TMC647055;   Drug: TMC435;   Drug: Placebo;   Drug: Ritonavir (RTV)
15 Active, not recruiting A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
Conditions: Hepatitis C, Chronic;   Infection
Interventions: Drug: TMC435;   Drug: Pegylated interferon alfa-2a (PegIFNα-2a);   Drug: Ribavirin (RBV)
16 Completed An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation
Condition: Chronic Hepatitis C Virus (HCV) Infection
Interventions: Drug: Telaprevir;   Drug: Pegylated interferon alfa-2a;   Drug: Ribavirin
17 Completed An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)
Condition: Chronic Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Drug: Pegylated-Interferon-alfa-2a
18 Terminated Total Marrow Irradiation Added to an Alkylator-Intense Conditioning Regimen for Patients With High Risk or Relapsed Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Kidney Cancer;   Liver Cancer;   Retinoblastoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: thiotepa;   Procedure: stem cell transplantation;   Radiation: tomotherapy;   Radiation: total marrow irradiation;   Drug: Mesna;   Radiation: Whole lung radiation
19 Unknown  EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis
Condition: Pancreatitis
Interventions: Drug: Magnesium  (15 mmol/d);   Drug: ANTOX (vers.) 1.2 (300 µg organic selenium, 54000 IU beta carotene, 750 mg vitamin C, 540 IU vitamin E, 2700 mg methionine)
20 Recruiting Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Conditions: Tumors;   Malignant Melanoma;   Hematological Malignancies;   Myelogenous Leukemia, Chronic;   Leukemia, Lymphoblastic, Acute
Interventions: Procedure: Immunoablative Hematopoietic PBSC Transplant;   Procedure: Busulfan pharmacokinetics;   Radiation: CNS prophylaxis radiation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years